Believe It Human Cd30 Ligand/tnfsf8 Protein (cd3-hm30l) With A 55% Price Cut [VxaHeGmF]

Believe It Human Cd30 Ligand/tnfsf8 Protein (cd3-hm30l) With A 55% Price Cut [VxaHeGmF]

Introducing the Believe It Human Cd30 Ligand/tnfsf8 Protein (cd3-hm30l) With A 55% Price Cut [VxaHeGmF], a high-quality recombinant protein designed for research purposes. This protein is a crucial component in the study of CD30, a tumor necrosis factor superfamily member, and plays a significant role in immune regulation and cell signaling. Our CD3-HM30L is produced through a state-of-the-art expression system, ensuring purity and functionality. Key features include:

• High purity and activity
• Recombinant protein for research applications
• Optimized for use in cell culture and immunoassays

Product Properties and Specifications

The Believe It Human Cd30 Ligand/tnfsf8 Protein (cd3-hm30l) With A 55% Price Cut [VxaHeGmF] is produced in a mammalian expression system, which provides a more natural and biologically relevant protein structure compared to bacterial or yeast systems. This protein is purified using proprietary chromatography techniques to ensure the highest level of purity. The protein is typically >95% pure as determined by SDS-PAGE and HPLC analysis. It is also biologically active, as demonstrated by its ability to bind to the CD30 receptor on T cells. Technical specifications include:

• Expression system: Mammalian
• Purity: >95% by SDS-PAGE and HPLC
• Activity: Bind to CD30 receptor on T cells

Practical Uses and Target Audience

The Believe It Human Cd30 Ligand/tnfsf8 Protein (cd3-hm30l) With A 55% Price Cut [VxaHeGmF] is an invaluable tool for researchers studying immune responses, cell signaling, and cancer biology. Its high purity and activity make it ideal for use in various applications, including cell culture, immunoassays, and in vitro studies. Whether you are investigating the role of CD30 in autoimmune diseases, analyzing the signaling pathways of T cells, or exploring novel cancer therapies, our CD3-HM30L can help you achieve your research goals. Target audience includes:

• Immunologists and immunotherapy researchers
• Cancer biologists and oncologists
• Biotechnology and pharmaceutical companies